Nordhealth As Stock Beta
| NORDH Stock | 43.00 6.00 16.22% |
Nordhealth AS fundamentals help investors to digest information that contributes to Nordhealth's financial success or failures. It also enables traders to predict the movement of Nordhealth Stock. The fundamental analysis module provides a way to measure Nordhealth's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nordhealth stock.
Nordhealth |
Nordhealth AS Company Beta Analysis
Nordhealth's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Nordhealth AS has a Beta of 0.0. This is 100.0% lower than that of the Healthcare sector and about the same as Health Information Services (which currently averages 0.0) industry. The beta for all Norway stocks is 100.0% lower than that of the firm.
Nordhealth Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nordhealth's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nordhealth could also be used in its relative valuation, which is a method of valuing Nordhealth by comparing valuation metrics of similar companies.Nordhealth is currently under evaluation in beta category among its peers.
Nordhealth Fundamentals
| Return On Equity | -0.11 | |||
| Return On Asset | -0.0552 | |||
| Profit Margin | (0.43) % | |||
| Operating Margin | (0.37) % | |||
| Current Valuation | 1.21 B | |||
| Shares Outstanding | 45.19 M | |||
| Shares Owned By Institutions | 50.31 % | |||
| Price To Book | 1.53 X | |||
| Price To Sales | 60.29 X | |||
| Revenue | 20.3 M | |||
| Gross Profit | 6.67 M | |||
| EBITDA | (369 K) | |||
| Net Income | (4.73 M) | |||
| Total Debt | 25 K | |||
| Book Value Per Share | 1.28 X | |||
| Cash Flow From Operations | 5.57 M | |||
| Earnings Per Share | (1.05) X | |||
| Target Price | 28.0 | |||
| Number Of Employees | 400 | |||
| Market Capitalization | 1.73 B | |||
| Total Asset | 125.13 M | |||
| Net Asset | 125.13 M |
About Nordhealth Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nordhealth AS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nordhealth using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nordhealth AS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Nordhealth Stock
Nordhealth financial ratios help investors to determine whether Nordhealth Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nordhealth with respect to the benefits of owning Nordhealth security.